Skip to main content

Day: June 24, 2021

Colliers launches strategic partnership with Blue Skyre to bolster innovative Facilities Management Advisory offering

Blue Skyre brings deep facilities management expertise to meet client needs ATLANTA, June 24, 2021 (GLOBE NEWSWIRE) — Leading diversified professional services and investment management company Colliers (NASDAQ and TSX: CIGI) today announced a global partnership with Blue Skyre IBE, LLC (“Blue Skyre”) to accelerate the growth of an innovative Facilities Management (“FM”) Advisory offering. Colliers’ differentiated advisory and consulting service helps clients improve their internal FM capabilities and organizational models, enhance supply chain performance by utilizing multiple FM service providers, and implement agile technology solutions. This global service offering benefits from Colliers’ independent position in the FM space and expands upon the FM advisory and consulting services already provided across Colliers’ Europe, Middle...

Continue reading

South Africa’s Vox Chooses Minim Cloud Software to Deliver Its Next-Gen Home WiFi Experience

Leading regional service provider will use Minim software platform to manage and secure subscriber networks with MikroTik routers and power the Vox Wi-Fi Home Manager App MANCHESTER, NH and JOHANNESBURG, June 24, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Minim, Inc. (OTCQB: MINM), the creator of innovative internet access products, today announced that Vox has chosen Minim’s AI-driven cloud software platform, mobile app, and customer care portal to underpin the Vox Wi-Fi Home Manager, an easy to use mobile app offering full Wi-Fi management, visibility, threat detection and device management. Wi-Fi Home Manager will initially be available to all Vox customers with the MikroTik hAP AC ² router, a popular choice for home WiFi in South Africa, and bundled in with all Fiber To The Home (FTTH) sales. The Vox network targets 400,000...

Continue reading

Angus Gold Appoints David Cobbold to its Board of Directors

TORONTO, June 24, 2021 (GLOBE NEWSWIRE) — Angus Gold Inc. (TSX-V: GUS | OTC: ANGVF) (“Angus” or the “Company”) is pleased to announce that Mr. David Cobbold will be joining the Company’s Board of Directors effective June 30, 2021. Mr. Cobbold is a veteran mining investment banker with 23 years of financial services experience. Currently, he is a Managing Director and Head of Mining at Macquarie Capital Markets Canada where he is responsible for sourcing and leading merger, acquisition, sale and defense transactions for clients ranging from exploration and development companies to global metals & mining companies. David’s clients are based in Canada, US, U.K, South African and Australia. In addition, David has extensive experience in global commodity and securities markets. Prior to joining Macquarie, David worked at CIBC World...

Continue reading

CloudMD Closes Acquisition of VisionPros, a Rapidly Growing Digital Eyewear Platform

VisionPros had revenue surpassing $22 million with Adjusted EBITDA margin exceeding 10% during 2020 VANCOUVER, British Columbia, June 24, 2021 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a healthcare technology company revolutionizing the delivery of care, is pleased to announce that it has closed the previously announced acquisition of VisionPros1, a vertically integrated digital eyewear platform that has serviced almost 1 million unique customers across North America. VisionPros conveniently delivers contact lenses and glasses right to their customer’s door, anywhere in North America, and at a fraction of the cost of traditional retail optical stores. The highly scalable business model includes a rapidly growing, e-commerce platform and innovative...

Continue reading

Vera Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update

Completed an initial public offering with net proceeds, including the exercise of the underwriters’ option in full, of approximately $48.4 million in May 2021 – – –Expanded the management team to support initiation of atacicept clinical development program– – –Initiated Phase 2b ORIGIN clinical trial of atacicept in patients with IgA nephropathy (IgAN) SOUTH SAN FRANCISCO, Calif., June 24, 2021 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA), a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today reported its financial results for the first quarter ended March 31, 2021, and provided a corporate update. “Over the past nine months, we completed two capital raises for a total of...

Continue reading

VSBLTY Partners with RapidSOS to Deliver Threat Detection Data to 911

• VSBLTY announces a partnership with RapidSOS and is now recognized as RapidSOS Ready• Through this partnership, VSBLTY sends life-saving emergency data directly to 911 through the RapidSOS Platform in an emergencyPhiladelphia, PA, June 24, 2021 (GLOBE NEWSWIRE) — VSBLTY Group Technologies Corp. (CSE: VSBY) (Frankfurt 5VS) (OTC: VSBGF) (“VSBLTY”), a leading provider of security and analytics technology, and RapidSOS announced today a partnership to provide first responders and 911 telecommunicators with the ability to access incident data from its industry-leading Vector™ software through RapidSOS. Built in partnership with public safety, RapidSOS’s emergency response data platform securely links life-saving data from over 350M connected devices directly to over 4,800 Emergency Communications Centers...

Continue reading

Miromatrix Medical Announces Pricing of Upsized Initial Public Offering

EDEN PRAIRIE, Minn., June 24, 2021 (GLOBE NEWSWIRE) — Miromatrix Medical Inc. (Nasdaq: MIRO) (“Miromatrix”), a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients’ lives, today announced the pricing of its initial public offering of 4,800,000 shares of common stock at a price to the public of $9.00 per share. In addition, Miromatrix has granted the underwriter a 30-day option to purchase up to an additional 720,000 shares of its common stock at the public offering price, less underwriting discounts and commissions. The common stock is expected to begin trading on The Nasdaq Capital Market under the ticker symbol “MIRO” on June 24, 2021, and the offering is expected to close on June 28, 2021, subject to the satisfaction...

Continue reading

Sugarbud Expands Product Portfolio In Ontario

CALGARY, Alberta, June 24, 2021 (GLOBE NEWSWIRE) — Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.DB, SUGR.WR, SUGR.WS, SUGR.WT,) (OTCQB: SBUDF) (“Sugarbud” or the “Company”) is pleased to announce the expansion of the Company’s product portfolio in Ontario with the launch of Mule Fuel. Mule Fuel is a very unique high-potency, high-terpene phenotype with a total THC range between 18-24% and terpene profiles between 3-5%. Learn More About The Sugarbud Craft Cannabis Collection Here “We are delighted to be expanding our Craft Cannabis Collection in the Province of Ontario – Canada’s largest and fastest growing recreational cannabis market,” stated Sugarbud’s CEO, John Kondrosky. “In addition to providing Ontario consumers with the potency profiles they are asking for, Mule Fuel is yet...

Continue reading

Aileron Therapeutics to be Added to the Russell Microcap® Index

BOSTON, June 24, 2021 (GLOBE NEWSWIRE) — Aileron Therapeutics (NASDAQ:ALRN), a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patients, announced today that it is set to join the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the U.S. market opens on June 28, 2021. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. “Protection against chemotherapy-induced toxicities represents a significant, largely unaddressed need in the oncology space, and one for which there is...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.